The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index"and Subject Rankings.
Lymphoma
Blood Cell Development and Function
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
122
62
0.508
cancer research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
112
44
0.393
Breast cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
86
35
0.407
Signal Transduction
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
85
38
0.447
Cancer
Targeted therapy
Signal Transduction
Polycystic Kidney Disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
81
40
0.494
Geniourinary Oncology
Kidney Cancer
Bladder Cancer
Clinical Trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
67
0.859
cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
43
0.614
Structural bioinformatics
computational structural biology
protein structure prediction
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
68
40
0.588
cancer
chromosomes
epigenetics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
67
30
0.448
Biostatistics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
42
0.667
protein folding
NMR
kinetics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
19
0.317
Urologic Cancers
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
59
45
0.763
Genetics
Biochemistry
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
27
0.491
Tumor microenvironment
cancer associated fibroblasts
extracellular matrix
pancreatic cancer
integrins
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
36
0.692
lymphoma biology
CLL biology
signaling pathways in lymphomagenesis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
29
0.592
Clinical Decision Making
Comparative Effectiveness
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
22
0.449
Immunology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
37
0.771
oncology drug development
gastroesophageal cancer
hepatobiliary cancers
gastrointestinal oncology
cancer survivorship
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
46
40
0.870
virology
hepatitis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
46
21
0.457
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
17
0.395
Systems biology
Molecular Biology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
29
0.690
Phase 1 drug development
Melanoma
Lung cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
32
0.780
Health Psychology
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
26
0.650
Genitourinary Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
34
0.895
Cancer
surgical oncology
melanoma
colorectal cancer
sarcoma
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
31
0.816
Richard I Fisher
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
122
62
0.508
Joseph R Testa
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
112
44
0.393
Jose Russo
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
86
35
0.407
Jonathan Chernoff
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
85
38
0.447
Signal Transduction
Oncology
Erica Golemis
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
81
40
0.494
Cancer
Targeted therapy
Signal Transduction
Polycystic Kidney Disease
Elizabeth Plimack
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
67
0.859
Geniourinary Oncology
Kidney Cancer
Bladder Cancer
Clinical Trials
John A Ridge
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
43
0.614
Roland Dunbrack
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
68
40
0.588
Structural bioinformatics
computational structural biology
protein structure prediction
Tim Yen
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
67
30
0.448
cancer
chromosomes
epigenetics
Brian Egleston
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
42
0.667
Heinrich Roder
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
60
19
0.317
Alexander Kutikov
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
59
45
0.763
Warren Kruger
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
27
0.491
Genetics
Biochemistry
Cancer
Edna (Eti) Cukierman
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
52
36
0.692
Tumor microenvironment
cancer associated fibroblasts
extracellular matrix
pancreatic cancer
integrins
Y Lynn Wang
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
29
0.592
lymphoma biology
CLL biology
signaling pathways in lymphomagenesis
J Robert Beck
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
22
0.449
Siddharth Balachandran
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
48
37
0.771
Crystal Denlinger
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
46
40
0.870
oncology drug development
gastroesophageal cancer
hepatobiliary cancers
gastrointestinal oncology
cancer survivorship
Christoph Seeger
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
46
21
0.457
Hormoz Ehya
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
17
0.395
Ilya Serebriiskii
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
42
29
0.690
Systems biology
Molecular Biology
Anthony Olszanski
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
32
0.780
Carolyn Fang
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
40
26
0.650
Daniel Geynisman
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
34
0.895
Jeffrey Farma
Fox Chase Cancer Center
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
31
0.816